Christopher Gibson - Aug 2, 2023 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Signature
/s/ Jonathan Golightly, attorney-in-fact
Stock symbol
RXRX
Transactions as of
Aug 2, 2023
Transactions value $
-$671,328
Form type
4
Date filed
8/4/2023, 05:51 PM
Previous filing
Jul 21, 2023
Next filing
Aug 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Options Exercise $98.9K +8.67K +0.95% $11.40 924K Aug 2, 2023 Direct F1
transaction RXRX Class A Common Stock Options Exercise $77.5K +31.3K +3.38% $2.48 956K Aug 2, 2023 Direct F1
transaction RXRX Class A Common Stock Sale -$793K -61K -6.38% $13.02 895K Aug 2, 2023 Direct F1, F2
transaction RXRX Class A Common Stock Sale -$54.3K -4.06K -0.45% $13.36 891K Aug 2, 2023 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXRX Stock Option (Right to Buy) Options Exercise $0 -8.67K -2.08% $0.00 408K Aug 2, 2023 Class A Common Stock 8.67K $11.40 Direct F1, F5
transaction RXRX Stock Option (Right to Buy) Options Exercise $0 -31.3K -5.56% $0.00 531K Aug 2, 2023 Class A Common Stock 31.3K $2.48 Direct F1, F6
holding RXRX Stock Option (Right to Buy) 814K Aug 2, 2023 Class A Common Stock 0 $8.55 Direct F4
holding RXRX Stock Option (Right to Buy) 5.44K Aug 2, 2023 Class A Common Stock 0 $11.40 Direct
holding RXRX Class B Common Stock 6.53M Aug 2, 2023 Class A Common Stock 0 $0.00 Direct F7
holding RXRX Class B Common Stock 527K Aug 2, 2023 Class A Common Stock 0 $0.00 by LAHWRAN-3 LLC F7, F8
holding RXRX Class B Common Stock 468K Aug 2, 2023 Class A Common Stock 0 $0.00 by LAHWRAN-4 LLC F7, F9
holding RXRX Class B Common Stock 122K Aug 2, 2023 Class A Common Stock 0 $0.00 by Gibson Family Trust F7, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 22, 2022.
F2 The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $12.35 to $13.34 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
F3 The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $13.35 to $13.43 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request
F4 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F5 The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F6 The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
F7 Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
F8 The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
F9 The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
F10 The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.